Best oral empirical treatment for pyelonephritis in children: Do we need to differentiate between age and gender?

Infect Dis (Lond). 2016 Oct;48(10):721-5. doi: 10.3109/23744235.2016.1168937. Epub 2016 Jun 14.

Abstract

Background: Pyelonephritis is a common infection in childhood and may cause renal scarring. The aim was to determine an effective oral antibiotic treatment of first time pyelonephritis in children.

Methods: The study is a retrospective analysis of positive urine cultures collected at a Danish paediatric department from 2010-2013. Urine samples from 378 children aged 0-15.9 years, without renal anomalies and treated for first time pyelonephritis, were included. The urine pathogens and antimicrobial susceptibilities were analysed.

Results: The most common aetiologic agents found were Escherichia coli (85%), Klebsiella species and other Enterobacteriaecea (9.7%) and Enterococcus species (5.3%). Escherichia coli was significantly more common in girls than in boys (90% vs 74%, p < 0.001) and in children older than 6 months (89% vs 77%, p < 0.001). Children younger than 6 months had a higher prevalence of other Gram-negative rods (16% vs 7%, p < 0.001). These differences may be due to boys representing 63% of patients in the youngest age group compared to 16% of older children (p < 0.001). For all urine isolates, piv-mecillinam and amoxicillin-clavulanate had the lowest resistance rates of 6.9% and 7.2%, respectively, and 6% for both antimicrobials in patients older than 6 months. Uropathogens from boys above 6 months of age were more resistant to piv-mecillinam compared to girls (25% vs 2.4%, p < 0.001).

Conclusion: This study recommends piv-mecillinam or amoxicillin-clavulanate as empirical treatment of first time pyelonephritis in Danish children from 6 months of age. Age and gender of patients should be taken into consideration when initiating empirical treatment.

Keywords: Pyelonephritis; age; amoxicillin-clavulanate; children; gender; oral antibiotic; paediatric.

MeSH terms

  • Administration, Oral
  • Adolescent
  • Age Factors
  • Amdinocillin Pivoxil / administration & dosage
  • Amdinocillin Pivoxil / pharmacology
  • Amoxicillin-Potassium Clavulanate Combination / administration & dosage
  • Amoxicillin-Potassium Clavulanate Combination / pharmacology
  • Anti-Bacterial Agents / administration & dosage*
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / epidemiology*
  • Bacterial Infections / microbiology
  • Child
  • Child, Preschool
  • Denmark / epidemiology
  • Drug Resistance, Bacterial
  • Enterococcus / drug effects
  • Enterococcus / isolation & purification
  • Escherichia coli / drug effects
  • Escherichia coli / isolation & purification
  • Female
  • Hospitals, Pediatric
  • Humans
  • Infant
  • Infant, Newborn
  • Klebsiella / drug effects
  • Klebsiella / isolation & purification
  • Male
  • Pyelonephritis / drug therapy*
  • Pyelonephritis / epidemiology*
  • Pyelonephritis / microbiology
  • Retrospective Studies
  • Sex Factors
  • Urine / microbiology

Substances

  • Anti-Bacterial Agents
  • Amdinocillin Pivoxil
  • Amoxicillin-Potassium Clavulanate Combination